Moomoo AI 已提取核心信息
On December 29, 2023, a Schedule 13G filing was made with the United States Securities and Exchange Commission (SEC) by The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC, indicating a significant investment in bluebird bio, Inc. The filing revealed that Goldman Sachs collectively owns 12,181,040 shares of bluebird bio, which represents approximately 0.4% of the company's common stock. The shares are held with shared voting and dispositive power. The filing was made under Rule 13d-1(b), which is typically used by passive investors to report holdings. The address for both The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC is 200 West Street, New York, NY. The filing included a certification that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer, nor in connection with any transaction having such purpose or effect.
On December 29, 2023, a Schedule 13G filing was made with the United States Securities and Exchange Commission (SEC) by The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC, indicating a significant investment in bluebird bio, Inc. The filing revealed that Goldman Sachs collectively owns 12,181,040 shares of bluebird bio, which represents approximately 0.4% of the company's common stock. The shares are held with shared voting and dispositive power. The filing was made under Rule 13d-1(b), which is typically used by passive investors to report holdings. The address for both The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC is 200 West Street, New York, NY. The filing included a certification that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer, nor in connection with any transaction having such purpose or effect.
2023年12月29日，高盛集团及其子公司高盛公司向美国证券交易委员会（SEC）提交了附表13G申报。有限责任公司表示对蓝鸟生物公司进行了大量投资。该文件显示，高盛共拥有蓝鸟生物的12,181,040股股份，约占该公司普通股的0.4％。这些股份以共同的投票权和处置权持有。该申报是根据规则13d-1（b）提交的，被动投资者通常使用该规则来报告持股情况。高盛集团和高盛公司的地址有限责任公司位于纽约州纽约西街 200 号。该文件包括一份证明，证明这些股票是在正常业务过程中收购的，不是为了改变或影响发行人的控制权，也不是与具有这种目的或效果的任何交易有关。
2023年12月29日，高盛集团及其子公司高盛公司向美国证券交易委员会（SEC）提交了附表13G申报。有限责任公司表示对蓝鸟生物公司进行了大量投资。该文件显示，高盛共拥有蓝鸟生物的12,181,040股股份，约占该公司普通股的0.4％。这些股份以共同的投票权和处置权持有。该申报是根据规则13d-1（b）提交的，被动投资者通常使用该规则来报告持股情况。高盛集团和高盛公司的地址有限责任公司位于纽约州纽约西街 200 号。该文件包括一份证明，证明这些股票是在正常业务过程中收购的，不是为了改变或影响发行人的控制权，也不是与具有这种目的或效果的任何交易有关。
有用
没用
